|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
82,823,000 |
Market
Cap: |
1.72(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$18.92 - $29.92 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 484 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
60,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$980,094 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
11,539 |
21,539 |
104,169 |
536,685 |
Total Sell Value |
$248,847 |
$492,446 |
$2,960,641 |
$14,057,583 |
Total People Sold |
2 |
3 |
4 |
8 |
Total Sell Transactions |
2 |
3 |
12 |
31 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Anderson Bonnie H |
President & CEO |
|
2016-06-03 |
4 |
B |
$5.32 |
$13,288 |
D/D |
2,500 |
10,000 |
2.81 |
- |
|
Anderson Bonnie H |
President & CEO |
|
2016-06-02 |
4 |
B |
$5.48 |
$13,693 |
D/D |
2,500 |
7,500 |
2.81 |
- |
|
Anderson Bonnie H |
President & CEO |
|
2016-06-01 |
4 |
B |
$5.46 |
$13,642 |
D/D |
2,500 |
5,000 |
2.81 |
- |
|
Anderson Bonnie H |
President & CEO |
|
2016-05-31 |
4 |
B |
$5.46 |
$13,644 |
D/D |
2,500 |
2,500 |
2.81 |
- |
|
Brooks Julie |
EVP, Gen. Counsel & Secretary |
|
2016-01-29 |
4 |
A |
$5.51 |
$1,548 |
D/D |
281 |
3,403 |
|
- |
|
Jones Evan/ Fa |
Director |
|
2015-11-25 |
4 |
S |
$7.23 |
$57,117 |
D/D |
(7,896) |
0 |
|
- |
|
Jones Evan/ Fa |
Director |
|
2015-11-25 |
4 |
OE |
$0.08 |
$632 |
D/D |
7,896 |
7,896 |
|
- |
|
Jones Evan/ Fa |
Director |
|
2015-11-24 |
4 |
S |
$7.20 |
$51,163 |
D/D |
(7,104) |
0 |
|
- |
|
Jones Evan/ Fa |
Director |
|
2015-11-24 |
4 |
OE |
$0.08 |
$568 |
D/D |
7,104 |
7,104 |
|
- |
|
Guyer Shelly D |
Chief Financial Officer |
|
2015-07-24 |
4 |
AS |
$12.47 |
$12,470 |
D/D |
(1,000) |
0 |
|
- |
|
Guyer Shelly D |
Chief Financial Officer |
|
2015-07-24 |
4 |
OE |
$6.04 |
$6,040 |
D/D |
1,000 |
1,000 |
|
- |
|
Hall Christopher M |
Chief Operating Officer |
|
2015-07-22 |
4 |
AS |
$11.85 |
$29,625 |
D/D |
(2,500) |
0 |
|
- |
|
Hall Christopher M |
Chief Operating Officer |
|
2015-07-22 |
4 |
OE |
$0.80 |
$2,000 |
D/D |
2,500 |
2,500 |
|
- |
|
Guyer Shelly D |
Chief Financial Officer |
|
2015-06-26 |
4 |
AS |
$12.08 |
$12,080 |
D/D |
(1,000) |
0 |
|
- |
|
Guyer Shelly D |
Chief Financial Officer |
|
2015-06-26 |
4 |
OE |
$6.04 |
$6,040 |
D/D |
1,000 |
1,000 |
|
- |
|
Halak Brian K |
10% Owner |
|
2014-09-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(300,000) |
2,763,294 |
|
- |
|
Hall Christopher M |
Chief Commercial Officer |
|
2014-09-10 |
4 |
AS |
$12.29 |
$12,290 |
D/D |
(1,000) |
0 |
|
- |
|
Hall Christopher M |
Chief Commercial Officer |
|
2014-09-10 |
4 |
OE |
$0.80 |
$800 |
D/D |
1,000 |
1,000 |
|
- |
|
Jones Evan/ Fa |
Director |
|
2014-09-09 |
4 |
S |
$12.60 |
$343,965 |
I/I |
(27,304) |
371,603 |
|
- |
|
Hall Christopher M |
Chief Commercial Officer |
|
2014-08-18 |
4 |
AS |
$12.92 |
$12,920 |
D/D |
(1,000) |
0 |
|
- |
|
Hall Christopher M |
Chief Commercial Officer |
|
2014-08-18 |
4 |
OE |
$0.80 |
$800 |
D/D |
1,000 |
1,000 |
|
- |
|
Brooks Julie |
Exec VP,General Coun,Secretary |
|
2014-07-22 |
4 |
AB |
$14.36 |
$14,364 |
D/D |
1,000 |
2,000 |
|
- |
|
Brooks Julie |
Exec VP,General Coun,Secretary |
|
2014-07-21 |
4 |
AB |
$14.00 |
$14,004 |
D/D |
1,000 |
1,000 |
|
- |
|
Hall Christopher M |
Chief Commercial Officer |
|
2014-07-10 |
4 |
AS |
$14.92 |
$44,768 |
D/D |
(3,000) |
0 |
|
- |
|
Hall Christopher M |
Chief Commercial Officer |
|
2014-07-10 |
4 |
OE |
$0.80 |
$2,400 |
D/D |
3,000 |
3,000 |
|
- |
|
524 Records found
|
|
Page 20 of 21 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|